Skip to main content
Premium Trial:

Request an Annual Quote

MDx Firm Lumora Raises $1.1M to Support Technology Commercialization

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Lumora today said it raised £700,000 ($1.1 million) in a follow-on financing as the company plans on further commercializing its technology in the US and Europe.

Current investors Tate & Lyle Ventures, Catapult Ventures Managers, and Cambridge University participated in the financing, which the Cambridge, UK-based firm said will go toward efforts to further commercialize its diagnostic technologies and applications, including the BART (Bioluminescent Assay in Real Time) system. BART is a reporter system for use with isothermal nucleic acid amplification technologies.

"During this quarter we have made significant progress with a number of commercial deals and the funding will allow us to further develop new products, take advantage of new opportunities, and accelerate existing commercial agreements," Laurence Tisi, CEO of Lumora, said in a statement.

In the spring of 2011, Lumora raised $2.1 million in second-stage funding.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.